Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Sensory Modalities01:15

Sensory Modalities

3.8K
Sensation typically is the process by which the sensory receptors and sense organs detect stimuli from the internal and external environment and transmit this information to the central nervous system for processing.
General senses refer to the broad category of sensory information detected by receptors in the body and can be further grouped into somatic and visceral senses. Somatic sensations include touch, pressure, temperature, and pain and are essential for navigating our environment and...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.0K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

845
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
845
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

969
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
969

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrin Alpha 4 Inhibition Prolongs the Survival of NSG Mice Engrafted with CD19-Negative Post-CART19 Relapsed B-ALL.

Experimental hematology·2026
Same author

Wnt signaling as a regulator of memory T cells: implications for CAR-T cell therapy.

Frontiers in immunology·2026
Same author

IFNγ Drives Long-Term Bone Marrow Niche Dysfunction Following Doxorubicin-Based Chemotherapy.

Blood·2026
Same author

Author Correction: BCL6 enables Ph<sup>+</sup> acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition.

Nature·2026
Same author

CD99Targeted Irinotecan Containing Nanoparticles Show Twenty-Fold Greater Anti-Tumor Effect Than Free Irinotecan For Treatment of Ewing Sarcoma.

bioRxiv : the preprint server for biology·2026
Same author

A K27-linked Ubiquitin Checkpoint Controls NOTCH Homeostasis.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Jan 24, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K

Targeted Nanoparticles: an Innovative Modality in the Treatment of Cancer.

Hyung-Gyoo Kang, Bryon Upton, Ryan W Holly

    Biorxiv : the Preprint Server for Biology
    |January 23, 2026
    PubMed
    Summary

    A new nano-antibody-drug conjugate (nADC/TNS) platform delivers significantly higher drug payloads to tumors than traditional antibody-drug conjugates (ADCs), improving cancer treatment efficacy.

    More Related Videos

    Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
    14:10

    Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

    Published on: December 15, 2010

    16.4K
    In Vivo Targeting of Xenografted Human Cancer Cells with Functionalized Fluorescent Silica Nanoparticles in Zebrafish
    10:26

    In Vivo Targeting of Xenografted Human Cancer Cells with Functionalized Fluorescent Silica Nanoparticles in Zebrafish

    Published on: May 8, 2020

    5.0K

    Related Experiment Videos

    Last Updated: Jan 24, 2026

    Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
    08:03

    Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

    Published on: December 1, 2016

    9.5K
    Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
    14:10

    Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

    Published on: December 15, 2010

    16.4K
    In Vivo Targeting of Xenografted Human Cancer Cells with Functionalized Fluorescent Silica Nanoparticles in Zebrafish
    10:26

    In Vivo Targeting of Xenografted Human Cancer Cells with Functionalized Fluorescent Silica Nanoparticles in Zebrafish

    Published on: May 8, 2020

    5.0K

    Area of Science:

    • Biotechnology
    • Nanomedicine
    • Oncology

    Background:

    • Traditional chemotherapy faces challenges with toxicity, efficacy, and off-target effects.
    • Encapsulating drugs or targeting them to tumor cells can overcome these limitations.
    • Existing antibody-drug conjugates (ADCs) offer targeted delivery but with limited payload capacity.

    Purpose of the Study:

    • To introduce and evaluate a novel targeted nanoparticle platform, nano-antibody-drug conjugate Targeted Nanosphere (nADC/TNS), for enhanced cancer therapy.
    • To demonstrate the versatility and efficacy of nADC/TNS with various antibody targets and drug payloads.
    • To compare the therapeutic potential of nADC/TNS against conventional treatments.

    Main Methods:

    • Preparation and characterization of nADC/TNS nanoparticles (approx. 80 nm) using phospholipids, cholesterol, and diacetylene lipids.
    • Development of nADC/TNS variants: NV101 (anti-CD99/doxorubicin), NV102 (anti-CD19/doxorubicin), and NV103 (anti-CD99/irinotecan).
    • In vivo evaluation of nADC/TNS efficacy in mouse models of Ewing sarcoma (ES) and adult lymphocytic leukemia (ALL).

    Main Results:

    • NV101 showed significant reduction in Ewing sarcoma tumor burden.
    • NV103 achieved complete ablation of Ewing sarcoma tumors.
    • NV102 demonstrated complete ablation of chemotherapy-resistant adult lymphocytic leukemia.
    • nADC/TNS exhibited superior efficacy compared to free drug equivalents.

    Conclusions:

    • The nADC/TNS platform offers a versatile and highly effective approach for cancer treatment.
    • nADC/TNS significantly enhances the efficacy of existing therapeutics through targeted delivery and high payload capacity.
    • This novel nanoparticle technology holds promise for treating various cancers and potentially other diseases.